Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
WDR92
REST API REST API
Homo sapiens
WDR92 is differentially expressed in 123 experiments: 47 organism parts: bone marrow, esophagus, ... (45 more);, 50 disease states: normal, , ... (48 more);, 44 cell types 202 cell lines 17 compound treatments and 34 other conditions.
Synonyms Monad, FLJ31741
Orthologs Q5F3H5_CHICK (Gallus gallus)   WDR92_BOVIN (Bos taurus)   CNB1 (Saccharomyces cerevisiae)   wdr92 (Danio rerio)   Wdr92 (Mus musculus)   RGD1563863 (Rattus norvegicus)   CanB2 (Drosophila melanogaster)   CanB (Drosophila melanogaster)   wdr92 (Xenopus laevis)   WDR92 (Canis familiaris)   (Compare orthologs)
InterPro Term WD40_repeat_dom, WD40_repeat, WD40_repeat_2, WD40_repeat_subgr
Gene Ontology Term protein binding, apoptosis, methylated histone residue binding, histone lysine methylation
UniProt Accession Q96CR6, Q96MX6, Q86YQ0, Q8ND98, E7EPU9
Search EB-eye ENSG00000243667
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-803, E-GEOD-6573, E-GEOD-18105, E-MTAB-69, ... (11 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-22152, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, ... (20 experiments)

Factor Value U/D Experiments
HL-60
2
E-MTAB-37, E-GEOD-24147
MCF-7
1
2
E-GEOD-19639, E-GEOD-20081, E-GEOD-5823
C7H2-R19E7
1
E-GEOD-22152
UMC11
1
E-MTAB-37
TANOUE
1
E-MTAB-37
COLO320DM
1
E-MTAB-37
196 more value(s).


Cell type

studied in E-GEOD-18811, E-GEOD-20193, E-GEOD-20033, E-TABM-130, E-GEOD-26672, ... (20 experiments)

Factor Value U/D Experiments
epithelial cell
1
E-GEOD-4483
iPS cells from episomal vectors (Defined Factor sub-clone)
1
E-GEOD-20033
CD4+ T cell
2
1
E-GEOD-16190
fibroblast
1
E-GEOD-26672
promyelocyte
1
E-GEOD-12662
liver cancer
1
E-GEOD-21154
38 more value(s).


Disease state

studied in E-GEOD-19743, E-GEOD-6872, E-GEOD-15960, E-TABM-311, E-GEOD-6919, ... (21 experiments)

Factor Value U/D Experiments
1
E-GEOD-19067
melanoma
1
E-MTAB-37
adrenocortical carcinoma
1
E-TABM-311
mesothelioma
1
E-MTAB-37
tumor
1
E-GEOD-19188
prostate cancer
1
E-GEOD-6919
44 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-20719, E-TABM-127, E-GEOD-6400, E-TABM-868, ... (11 experiments)

Factor Value U/D Experiments
unknown
1
E-GEOD-7307
Cxcl12
1
E-GEOD-7307
1mM GDC-0941
1
E-GEOD-20719
TTA
1
E-MEXP-2590
ethanol
1
E-MEXP-2241
not specified
1
E-GEOD-20081
11 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21589, E-GEOD-16363

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22148, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-4086

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (7 experiments)

Genotype
studied in E-TABM-1029, E-MEXP-421, E-TABM-868, E-TABM-601, E-GEOD-17347 ... (5 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-TABM-127, E-GEOD-20540, E-MEXP-1103, E-TABM-440

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-19330, E-TABM-666, E-GEOD-19519, ... (13 experiments)

Injury
studied in E-GEOD-19743

Metastasis
studied in E-GEOD-18105

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

RNAi
studied in E-MEXP-2115, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743

Sex
studied in E-GEOD-1643, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

Subtype
studied in E-GEOD-24283

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-12198

Tumor grading
studied in E-GEOD-4290

Processing time: 0.407 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM